76 related articles for article (PubMed ID: 11522034)
41. Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France.
; Leizorovicz A; Cohen A; Guenoun M; Mismetti P; Weisslinger N
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):32-8. PubMed ID: 17063535
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
Leey JA; McCabe S; Koch JA; Miles TP
Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
[TBL] [Abstract][Full Text] [Related]
43. [Hereditary resistance to vitamin K antagonists. Apropos of a case].
Paganelli F; Conard J; Gelisse R; Ricard P; Samama M; Lévy S
Arch Mal Coeur Vaiss; 1999 Jun; 92(6):757-9. PubMed ID: 10410814
[TBL] [Abstract][Full Text] [Related]
44. Stabilization of anticoagulant therapy by simultaneous coumarin and vitamin K administration.
Udall JA
Angiology; 1968 Feb; 19(2):95-102. PubMed ID: 4868165
[No Abstract] [Full Text] [Related]
45. Warfarin reversal: schism between clinical practice and published guidelines.
Shah N; Sarode R
Transfusion; 2013 Mar; 53(3):476-9. PubMed ID: 23473063
[No Abstract] [Full Text] [Related]
46. Watch for severe reactions to vitamin K.
Porterfield LM
RN; 1993 Nov; 56(11):87. PubMed ID: 8235332
[No Abstract] [Full Text] [Related]
47. Pharmacokinetics of warfarin following intravenous administration to man.
O'Reilly RA; Welling PG; Wagner JG
Thromb Diath Haemorrh; 1971; 25(1):178-86. PubMed ID: 5577970
[No Abstract] [Full Text] [Related]
48. [The pharmacokinetics of vitamin K3-sodium bisulfite as a thermal sensitizer for cancer cells].
von Ardenne M; Reitnauer PG; Rieger F
Arch Geschwulstforsch; 1967; 30(4):284-306. PubMed ID: 5628324
[No Abstract] [Full Text] [Related]
49. Warfarin dosage and vitamin K in Osmolite.
Lader E; Yang L; Clarke A
Ann Intern Med; 1980 Aug; 93(2):373-4. PubMed ID: 7406391
[No Abstract] [Full Text] [Related]
50. Vitamin K1 and therapy of massive warfarin overdose.
Shearer MJ; Barkhan P
Lancet; 1979 Feb; 1(8110):266-7. PubMed ID: 84915
[No Abstract] [Full Text] [Related]
51. No acute toxicity after massive anticoagulant overdose.
Kuijpers PM; Janknegt R; Moers AM; Hooymans PM; Bas BM
Neth J Med; 1993 Aug; 43(1-2):92-3. PubMed ID: 8232702
[No Abstract] [Full Text] [Related]
52. [Interference of HCO-60 (solvent of vitamin K2) on the serum total lipid estimation].
Iizuka K; Higurashi H; Fujimoto J; Hayashi Y
Rinsho Byori; 1987 Jun; 35(6):659-62. PubMed ID: 3669375
[No Abstract] [Full Text] [Related]
53. The distribution of warfarin (Coumadin) in the rat.
Anderson GF
Thromb Diath Haemorrh; 1967 Dec; 18(3-4):754-8. PubMed ID: 5590254
[No Abstract] [Full Text] [Related]
54. Injectable vitamin K3.
Nangeroni LL
J Am Vet Med Assoc; 1986 Oct; 189(8):850. PubMed ID: 3771348
[No Abstract] [Full Text] [Related]
55. Warfarin overdose with a side of munchausen.
Mohammed D
J Family Med Prim Care; 2019 Sep; 8(9):3071. PubMed ID: 31681701
[No Abstract] [Full Text] [Related]
56. Massive Aspirin Overdosage.
Oakley W; Donnell JP
Br Med J; 1942 Jun; 1(4251):787-9. PubMed ID: 20784302
[No Abstract] [Full Text] [Related]
57. OVERDOSAGE WITH VITAMIN D.
Br Med J; 1937 Jun; 1(3989):1269-70. PubMed ID: 20780741
[No Abstract] [Full Text] [Related]
58. Efficacy of intravenous vitamin K in a case of massive warfarin overdosage.
Kitchens CS
Thromb Haemost; 2001 Aug; 86(2):719-20. PubMed ID: 11522034
[No Abstract] [Full Text] [Related]
59. Reversal of warfarin: case-based practice recommendations.
Garcia DA; Crowther MA
Circulation; 2012 Jun; 125(23):2944-7. PubMed ID: 22689931
[No Abstract] [Full Text] [Related]
60. Warfarin: effects of intravenous loading doses and vitamin K on warfarin anticoagulation in the pony.
Scott EA; Sandler GA; Byars TD
Am J Vet Res; 1978 Dec; 39(12):1888-91. PubMed ID: 749570
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
